新千年早期炎症性关节炎患者的10年结局较前十年是否改善?诺福克关节炎登记研究结果
比较诺福克关节炎登记中1990—1994年与2000—2004年招募的两组炎症性多关节炎患者的10年结局。新千年队列10年间肿胀51关节计数低17%,但压痛关节计数和健康评估问卷残疾无差异;全因和心血管死亡风险在调整一般人群死亡风险变化后无显著差异。
要点
- 新千年队列10年肿胀51关节计数较前队列低17%(95%CI -23%至-10%)。
- 两队列压痛51关节计数和健康评估问卷残疾无差异。
- 调整一般人群死亡风险变化后,全因和心血管死亡差异无统计学显著。
核心结论
- 新千年炎症性多关节炎患者疾病活动度显著改善,而残疾和死亡无变化。
研究设计与样本
- 研究为诺福克关节炎登记中1990—1994年招募的队列1(1022例)与2000—2004年招募的队列2(631例)比较,共1653例炎症性多关节炎患者,基线及第1、2、3、5、7、10年收集人口学和临床数据。
主要发现
- 队列2在10年间肿胀51关节计数较队列1低17%(95%CI -23%至-10%),压痛51关节计数和健康评估问卷残疾两组相当。
- 队列2全因死亡风险低于队列1(HR 0.72,95%CI 0.56至0.95),心血管死亡风险低于队列1(亚分布风险比0.58,95%CI 0.37至0.93)。
- 调整一般人群死亡风险变化后,全因死亡差异无统计学显著(死亡率比0.78,95%CI 0.56至1.10),心血管死亡差异无统计学显著(死亡率比0.77,95%CI 0.48至1.24)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the 10-year outcome (disease activity, disability, mortality) of two cohorts of patients with inflammatory polyarthritis (IP) recruited 10 years apart. METHODS: Patients with IP were recruited to the Norfolk Arthritis Register from 1990 to 1994 (cohort 1 (C1)) and from 2000 to 2004 (cohort 2 (C2)). Demographic and clinical data were collected at baseline and at years 1, 2, 3, 5, 7 and 10. Longitudinal disease activity (swollen/tender 51 joint counts (SJC51/TJC51)) and disability (Health Assessment Questionnaire (HAQ)) were compared between the cohorts using population-average negative binomial regression and generalised estimating equation analysis, respectively. Risk of 10-year mortality was compared between cohorts using Cox models. Risk of cardiovascular disease (CVD) mortality was compared between cohorts using competing risks analysis. Mortality rate ratios (MRR), adjusted for changes in mortality risk of the general population, were calculated using Poisson regression. RESULTS: In total 1653 patients were recruited (C1=1022, C2=631). Patients in C2 had 17% lower SJC51 than C1 over 10 years (95% CI -23% to -10%), whereas TJC51 and HAQ were comparable. C2 patients had reduced risk of all-cause and CVD mortality compared with C1 (all-cause: HR 0.72, 95% CI 0.56 to 0.95; CVD: subhazard ratio 0.58, 95% CI 0.37 to 0.93). After accounting for changes in mortality risk in the general population, the difference in mortality was non-significant (all-cause: MRR 0.78, 95% CI 0.56 to 1.10; CVD: MRR 0.77, 95% CI 0.48 to 1.24). CONCLUSION: Disease activity significantly improved in the new millennium, whereas disability and mortality were unchanged.
引用
- Gwinnutt JM, Symmons DPM, MacGregor AJ, et al. Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis Register. Ann Rheum Dis. 2018. PMID: 29475855. doi:10.1136/annrheumdis-2017-212426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。